+499.5%
MRNA vs FCEL
+269.1%
+230.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.9% | -4.1% | -2.4% |
| 7D | +5.5% | -15.8% | +21.3% | +6.7% |
| 30D | +158.7% | -29.3% | +188.0% | +163.9% |
| 3M | +182.1% | -30.1% | +212.3% | +180.5% |
| 6M | +151.8% | +74.4% | +77.4% | +117.8% |
| YTD | +393.6% | +104.5% | +289.0% | +318.4% |
| 1Y | +499.5% | +281.4% | +218.1% | +354.5% |
| All | +499.5% | +269.1% | +230.3% | +354.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling